FDA approves Cobenfy for adults with schizophrenia
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...
The Hindu23d
FDA approval for Cobenfy casts light on schizophrenia’s wickedness
On September 26, the U.S. Food and Drug Administration (FDA) approved a drug called Cobenfy to treat schizophrenia. Cobenfy is a combination of xanomeline and trospium chloride that has a novel ...
BioWorld5d
Autolus’ CAR T Aucatzyl wins US FDA nod for leukemia
Benefiting from the news, however, was Bristol Myers Squibb Co., which gained U.S. FDA approval in September 2024 for Cobenfy (xanomeline-trospium), a dual M1/M4 muscarinic agonist, with shares ...
pharmaphorum4d
BMS ends decades-long drought in novel schizophrenia drugs
And Cobenfy's approval comes after two other recent setbacks in the late-stage schizophrenia pipeline; namely, the FDA’s rejection of Minerva Neurosciences’ application for roluperidone and ...
Nasdaq2d
What's Happening With AbbVie Stock?
However, this came as good news for investors in AbbVie’s peer Bristol Myers Squibb (NYSE:BMY) as the company recently secured the U.S. FDA approval for its schizophrenia drug Cobenfy ...
CBS News8d
FDA to pull common but ineffective cold medicine from market
The FDA's proposal comes more than a year after the agency's outside advisers voted against continued use of the ingredient, called oral phenylephrine, citing concerns with the initial data used ...
Pharmaceutical Technology10d
Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals
The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...
The Hill23d
FDA recalls thousands of antidepressant bottles due to cancer-causing chemical
The Food and Drug Administration (FDA) issued a Class II recall of more than 7,100 bottles of the antidepressant duloxetine due to the possible presence of a carcinogen. Duloxetine belongs to a ...
USA Today23d
FDA recalls more than 7,000 bottles of antidepressant over a possible cancerous chemical
Per the FDA, nitrosamine impurities "may increase the risk of cancer if people are exposed to them above acceptable levels and over long periods of time." However, it added, "a person taking a ...
Ars Technica8d
After decades, FDA finally moves to pull ineffective decongestant off shelves
Specifically, the FDA issued a proposed order to remove oral phenylephrine from the list of drugs that drugmakers can include in over-the-counter products—also known as the OTC monograph.
New York Post23d
Thousands of bottles of common antidepressant Cymbalta recalled by FDA over cancer-causing chemical
Thousands of bottles of a commonly prescribed antidepressant drug have been recalled by the FDA because they were found to contain a suspected cancer-causing chemical. Over 7,100 bottles of ...
Yahoo8d
FDA proposes removing ineffective decongestant found in most cold medicine
(The Hill) — The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral over-the-counter cold medicines because it doesn’t work. The move ...